Increased motility is one of the characteristics of cancer cells, and actin polymerization and disassembly are essential for cellular motility. Since actin-related protein (Arp) 2/3 complex acts as a nucleus for actin polymerization, in this study, we immunohistochemically investigated the expression of Arp2 and Arp3 in 175 colorectal tumors in various stages of neoplastic progression. Arp2 and Arp3 showed identical expression patterns, and both were expressed in the stromal cells around neoplastic tubules or glands and in the tumor cells themselves. The frequency of expression of Arp2 and Arp3 (Arp2&3) by the stromal cells increased with the atypia of the colorectal neoplasms, from 5.5% (3/55) in adenoma with mild or moderate atypia, to 11.8% (2/17) in adenoma with severe atypia, 53.3% (16/30) in intramucosal carcinoma, and 91.8% (67/73) in invasive carcinoma (Po0.0001). The frequency of expression of Arp2&3 in the tumor cells was similar and was 1.8% (1/55) in adenoma with mild or moderate atypia, 23.5% (4/17) in adenoma with severe atypia, 23.5% (7/30) in intramucosal carcinoma, and 32.9% (24/73) in invasive carcinoma. Expression of Arp2&3 by the stromal cells was significantly correlated with nuclear accumulation of p53 in the tumor cells and stromal expression of CD10. These results suggest that formation of Arp2/3 complex by both neoplastic and stromal cells contributes to the increased motility of both cell types and thus provides suitable conditions for invasion.
Cell movement is mediated by the formation and disassembly of actin filaments and is indispensable to embryogenesis, organogenesis, the inflammatory reaction process, and cancer invasion and metastasis. Three G proteins of the Rho family-Rho, Cdc42, and Rac-are involved in the control of actin polymerization, 1 and the genes of Wiskott-Aldrichsyndrome-related protein (WASP) and actin-related proteins (Arps) 2 and 3 have recently been demonstrated in the downstream of the genes of three G proteins. 2, 3 Arp2/3 complex has been identified as binding to profilin, it consists of seven subunits, including Arp2 and Arp3. 4 The Arp2/3 complex acts as a nucleus for actin polymerization and directly regulates the polymerization reaction by interacting with WASP family proteins. 5, 6 Although many studies have demonstrated the intracellular localization of the Arp2/3 complex, the types of cells and/ or tissues that express it in vivo and how it works are unclear.
Invasion and metastasis begin with the movement of cancer cells from the primary focus in cancer tissue, and actin polymerization is necessary for this movement to occur. However, other factors such as cell adhesion and matrix degradation are also involved in the generation of cell movement. To understand the biological significance of the formation of Arp2/3 complex, we investigated the expression of Arp2 and Arp3 in the process of colorectal carcinogenesis and the relation between their expression and cancer invasion by immunohistochemically investigating the expression of Arp2 and Arp3 in colorectal neoplastic lesions in various stages of carcinogenesis.
Materials and methods

Patients and Tumor Specimens
We analyzed specimens of colorectal neoplasms from 175 Japanese patients, 159 of whom had undergone surgical resection and 16 of whom had done endoscopic resection at the Tokyo Medical University Hospital. Of the 175 cases, 169 had been used in our previous study. 7 Blocks of formalinfixed, paraffin-embedded tissue of colorectal neoplasms were retrieved from the Surgical Pathology Division, and serial sections of each block were cut. One section was stained with hematoxylin and eosin (H & E) for confirmation of the histopathological diagnosis by three pathologists. The histological diagnosis and depth of invasion were determined according to the Japanese classification of colorectal carcinoma. 8 Briefly, the adenomas were classified into three grades of atypia according to their degree of cytological and architectural atypia: mild, moderate, or severe. When carcinoma cells were limited to the mucosa, the term 'intramucosal carcinoma' was used. Intramucosal carcinoma included carcinoma in adenoma and carcinoma without an adenomatous component, or de novo cancer. The term 'invasive carcinoma' was restricted to cancer that had invaded the submucosa or beyond.
Immunohistochemical Staining of Arp2, Arp3, CD10, and p53
One or two representative blocks from each tumor were selected for immunohistochemical analysis of Arp2 and Arp3. Serial 4-mm-thick sections were cut from each paraffin block, and the sections were routinely deparaffinized with xylene, rehydrated with a series of ethanol washes, and then immersed in 0.3% hydrogen peroxide in absolute methanol for 15 min to block endogenous peroxidase activity. Nonenzymatic antigen retrieval was performed by autoclave heating in 0.01 M sodium citrate buffer (pH 6.0) for 5 min. After cooling, the sections were incubated with 10% normal swine serum in phosphate-buffered saline for 10 min, and a biotinblocking system (DAKO Japan, Kyoto, Japan) was used to block endogenous biotin. The sections were then incubated with an anti-Arp2 goat monoclonal antibody (K-15, Santa Cruz Biotechnology, Santa Cruz, CA, USA) diluted to 1:1000 or an anti-Arp3 polyclonal antibody. The anti-Arp3 polyclonal antibody was generated by immunizing rabbits with the synthetic peptide CKVFMQEFKEGRRASH-TAPQVLFSHRE, which corresponds to amino acids 178-204 of Arp3, and is superior to the commercially available monoclonal antibody against Arp3 (G-15, Santa Cruz Biotechnology), as it yielded higher signal intensity and lower background staining of colon samples. Therefore, the polyclonal antibody diluted to 1:5000 was selected for use in the study. The sections of colon cancer tissue, which Arp2 and Arp3 were confirmed to be expressed by immunoblot analysis, were used for the positive control of immunostaining of Arp2 and Arp3. For the negative control, the primary antibody was substituted by normal rabbit serum. Smooth muscle cells of small blood vessels were used as a built-innegative control in each section. CD10 and p53 were immunostained with an anti-CD10 mouse monoclonal antibody (56C6, Novocastra, Newcastle-uponTyne, UK) diluted to 1:100 and an anti-p53 mouse monoclonal antibody (DO-7, DAKO Japan) diluted to 1:200.
An LSAB kit (DAKO Japan) was used as the detection system. After incubating the sections with biotin-labeled secondary antibodies and horseradish peroxidase-labeled streptavidin, the color reaction was developed in 0.02% 3 0 ,3 0 -diaminobenzidine hydrochloride and 0.02% H 2 O 2 in Tris buffer (pH 8.0). Hematoxylin was used for counterstaining.
Evaluation of Immunostaining
Arp2 and Arp3 expression was evaluated separately in the stromal and tumor cells. When neoplastic tubules or glands were surrounded by stromal cells expressing Arp2 and/or Arp3, expression by the stromal cells was judged to be positive. If more than 10% of the tumor cells expressed Arp2 and/or Arp3, expression by the tumor cells was judged to be positive. Three observers independently judged the results of immunostaining. Interobserver discordance was detected in a few cases. A consensus for these cases was reached after discussion using a multihead teaching microscope.
Expression of CD10 by the stromal cells was evaluated in the same manner as expression of Arp2 and Arp3. The tumor cells were judged to be p53-positive when more than 10% of the nuclei clearly stained.
Statistical Analysis
Correlations between the clinicopathological features of the patients, and Arp2 and Arp3 expression were analyzed by the w 2 test. A P-value of o0.05 was considered indicative of statistical significance. Statistical data were analyzed with the SAS statistical package (StatView 5.0, SAS Institute Inc., Cary, NC, USA).
Results
Distribution of Arp2 and Arp3
The distribution of Arp2 in colorectal tissue coincided with that of Arp3, and identical expression of Arp2 and Arp3 (Arp2&3) was observed in lymphocytes, neutrophils, macrophages, and vascular endothelial cells (Figure 1 ). No expression of Arp2&3 was detected in the epithelial cells or stromal cells of normal mucosa, but expression of Arp2&3 was detected in the stromal cells adjacent to the neoplastic ducts of adenomas and carcinomas, and in the tumor cells themselves (Figures 2 and 3) . The distribution of Arp2 and Arp3 in the stromal cells 
Frequency of Expression of Arp2&3 in Stromal Cells During Progression of Colorectal Neoplasms
Arp2&3 were expressed by the stromal cells of three (5.5%) of the 55 adenomas with mild-to-moderate atypia and in two (11.8%) of the 17 adenomas with severe atypia. They were positive in 16 (53.3%) of the 30 intramucosal carcinomas and in 67 (91.8%) of the 73 invasive carcinomas. The frequency of Arp2&3 expression was higher in carcinoma tissue than in adenoma tissue (Po0.0001), and significantly higher frequency of Arp2&3 expression was observed in the stromal cells of invasive carcinomas than of noninvasive carcinomas and adenomas (Po0.0001) ( Table 1) .
Frequency of Expression of Arp2&3 in Tumor Cells During Progression of Colorectal Neoplasms
Arp2&3 expression by the tumor cells was observed in one (1.8%). of the 55 adenomas with mild-tomoderate atypia and in four (23.5%) of the 17 adenomas with severe atypia. Arp2&3 expression was positive in the tumor cells in seven (23.3%) Table 2 ). The frequency of Arp2&3 expression was higher in the adenomas with severe atypia and carcinomas than in the adenomas with mild-to-moderate atypia (Po0.0001). 
Correlation between Arp2&3 Expression and Depth of Invasion by Colorectal Cancer
Correlation between Expression of CD10 and Arp2&3 by Stromal Cells
CD10 has been shown to be expressed by tumorinduced stromal cells. 7 The stromal cells in 86 (49.1%) of 175 tumors were positive for CD10. Stromal expression of Arp2&3 was observed in 61 (Table 5) . As shown in Figure 5 , the distribution of CD10 and Arp2 was nearly the same.
Correlation between Expression of p53 and Arp2&3 by Stromal Cells
Accumulation of p53 in the nuclei of tumor cells was observed in 84 (48.0%). of the 175 tumors. Stromal expression of Arp2&3 was seen in 60 (71.4%) of the 84 p53-positive tumors, and there was a significant correlation between the occurrence of p53 in the nuclei and Arp2&3 expression ( Table 6 ).
Discussion
Attempts have been made to elucidate intracellular signaling during cell movement, and direct involvement of the Arp2/3 complex has been demonstrated when actin filaments polymerize rapidly after exposure to various stimuli. Many reports have shown intracellular localization of the Arp2/3 complex in normal tissues, 9-12 but there have been no reports on its distribution in cancer tissue. We detected identical expression of Arp2 and Arp3 by the neoplastic cells and the stromal cells of colorectal neoplasms. Since the distribution of Arp2 was the same as that of Arp3 in tumorous colorectal tissue, we concluded that the identical expression of Arp2 and Arp3 indicates the formation of Arp2/3 complex.
Arp2&3 were not expressed in the epithelium or stromal cells of normal colorectal mucosa, but their expression was detected in macrophages, lymphocytes, and endothelial cells. As these cells are thought to function while migrating in tissues, cells that express Arp2&3 may have greater ability to move freely than cells that do not. Similarly, the expression of Arp2&3 by cancer and stromal cells partly explains their ability to migrate actively.
We previously reported that CD10 is expressed by stromal cells adjacent to neoplastic glands in colorectal cancer, and that CD10 is a marker for stromal cells that have been activated by tumor cells. 7 The fact that the expression of Arp2&3 was correlated with that of CD10 and the distribution of the cells Arp2&3 expression in colorectal tumor T Otsubo et al expressing these two markers matched suggests that Arp2&3 is probably expressed by stromal cells that have been induced by tumor cells.
Arp2&3-positive stromal cells were rarely seen in low-grade adenomas, but they tended to become more frequent with the morphological progression of colorectal tumor. Arp2&3-positive stromal cells were seen in a high percentage of invasive carcinomas, and there was a significant difference in the frequency of Arp2&3-positive stromal cells between noninvasive intramucosal lesions and invasive carcinomas. Their occurrence was also correlated with abnormal accumulation of p53 protein. The emergence of stromal cells that expressed Arp2&3 appeared to be closely associated with the transformation of adenomas with severe atypia into carcinomas.
Analysis according to depth of invasion by colorectal cancer showed that tumor cells were more frequently positive for Arp2&3 as the invasion increased, and Arp2&3 expression by the cancer cells was more often seen at the invasive front of the cancer. These observations also pointed to the involvement of Arp2&3 expression in cancer invasion following carcinogenesis.
Arp2&3 were more strongly expressed by the stromal cells than by the cancer cells, and Arp2&3 expression tended to be greater in the stromal cells at the invasive front of the cancer. These observations suggest that the stromal cells expressing Arp2&3 move and grow in advance of the cancer cells to prepare an environment that facilitates cancer cells' invasion, and indeed myofibroblasts, which are considered cancer-induced stromal cells, have been shown to affect the adhesion and movement of cancer cells. 13 Other studies have shown that patients whose cancer exhibits marked fibrosis have a poorer outcome than those who have cancer without significant fibrosis. 14, 15 The ability of cancer cells to invade is controlled by tumor-stromal interaction. Stromal cells have been reported to control cancer cell adhesion and movement, [16] [17] [18] and stromal cells produce cytokines, including interleukin (IL)-1.
19-21 Actin fiber formation mediated by the action of the Arp2/3 complex begins rapidly when cell migration is induced by cytokines. Activated fibroblasts also produce transforming growth factor-b, matrix metalloproteinase (MMP) 11, and hepatocyte growth factor (HGF), which are involved in cancer cell invasion. [21] [22] [23] [24] [25] [26] [27] HGF, in particular, is known to be induced by cancer-cellderived IL-1, platelet-derived growth factor, basic fibroblast growth factor, epidermal growth factor, and prostaglandins, and to play a role as a mediator of tumor-stromal interaction in various types of malignancy. 28, 29 Many studies have reported overexpression of cMet or an HGF receptor by colorectal cancer. [30] [31] [32] [33] Increased cell movement induced by HGF requires activation of Rho protein, and Rac and Rho are involved in cell membrane ruffling during the cell movement caused by HGF. 34 HGF controls the WASP family protein N-WASP, and is related to cell movement and invasion. 35 HGF appears to activate the Arp2/3 complex and promote cell scattering. A model of invasion that used various cancer cell lines has indicated involvement of the Rho family in cancer invasion. [36] [37] [38] Invasion presumably occurs by a similar system in vivo, and the Arp2/3 complex is thought to be controlled by tumor-stromal interaction and to be involved in cancer invasion.
The results of our study indicated that the Arp2/3 complex may be involved in the invasion of colorectal cancer. Further studies on the role of the Arp2/3 complex in tumor-stromal interaction are needed to develop effective cancer therapy by inhibiting cancer cell movement.
